Facts on fats

Clinical and Experimental Ophthalmology

Volumn 34, Issue 5, 2006, Pages 464-471

  Chong, Elaine W T ^a   Sinclair, Andrew J ^b   Guymer, Robyn H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Age related macular degeneration; Fatty acid; Omega 3 fatty acid; Omega 6 fatty acid trans unsaturated fat

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; CHOLESTEROL; COD LIVER OIL; COPPER; FATTY ACID; FISH OIL; FLAVONOID; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYTYROSOL; ICOSANOID; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MONOUNSATURATED FATTY ACID; NICOTINIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYPHENOL; POLYUNSATURATED FATTY ACID; POTASSIUM; PYRIDOXINE; RESVERATROL; SATURATED FATTY ACID; TRANS FATTY ACID; UNINDEXED DRUG; VEGETABLE OIL; ZINC;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLEEDING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; DRUG MECHANISM; FOOD INTAKE; HUMAN; PATHOGENESIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR;

DIETARY FATS; FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MACULAR DEGENERATION;

EID: 33745873472     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01250.x     Document Type: Review

References (60)

1. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: Association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003; 121: 1728-37.
2. Seddon JM, Rosner B, Sperduto RD et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001; 119: 1191-9.
3. Heuberger RA, Mares-Perlman JA, Klein R, Klein BE, Millen AE, Palta M. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch Ophthalmol 2001;119: 1833-8.
4. Cho E, Hung S, Willett WC et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73: 209-18.
5. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 2000; 118: 401-4.
6. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995; 113: 743-8.
7. Seddon J, Ajani U, Sperduto R et al. Dietary fat intake and age-related macular degeneration [ARVO, abstract 3454a]. Invest Ophthalmol Vis Sci 1994; 35: 2003.
8. Sheraidah G, Steinmetz R, Maguire J, Pauleikhoff D, Marshall J, Bird AC. Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology 1993; 100: 47-51.
9. Potts AM. An hypothesis on macular disease. Trans Am Acad Ophthalmol Otolaryngol 1966; 70: 1058-62.
10. Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 1992; 70: 66-72.
11. Ohtani H, Hayashi K, Hirata Y et al. Effects of dietary cholesterol and fatty acids on plasma cholesterol level and hepatic lipoprotein metabolism. J Lipid Res 1990; 31: 1413-22.
12. Gurr MI. Role of Fats in Food and Nutrition. London: Elsevier Applied Science Publishers, 1984.
13. Clarke R, Frost C, Collins R, Appleby P, Peto W. Dietary lipids and blood cholesterol. Quantitative meta-analysis of metabolic ward studies. Brit Med J 1997; 314: 112-17.
14. Goldstein JL, Brown MS. Lipoprotein receptors: Genetic defence against Atherosclerosis. Clin Res 1984; 32: 412-25.
15. Woollett LA, Spady DK, Dietschy JM. Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J Lipid Res 1992; 33: 77-88.
16. Eastwood M. Principles of Human Nutrition, 1st edn. London: Chapman & Hall, 1997.
17. Karupaiah T, Noor MI, Sundram K. Dietary fatty acids and their influence on blood lipids and lipoproteins. In: Akoh CC, Lai O-M, eds. Healthful Lipids. Champaign: AOCS Press, 2005; 171-203.
18. Keys A. Coronary heart disease in seven countries. Circulation 1970; 41: 1162-75.
19. Willett WC, Ascherio A. Trans fatty acids: Are the effects only marginal? Am J Public Health 1994; 84: 722-4.
20. Ratnayake WM, Zehaluk C. Trans fatty acids in foods and their labeling regulations. In: Akoh CC, Lai O-M, eds. Healthful Lipids. Champaign: AOCS Press, 2005; 1-32.
21. Zock PL, Mensink RP. Dietary trans-fatty acids and serum lipoproteins in humans. Curr Opin Lipidol 1996; 7: 34-7.
22. Akoh CC. Structured and specialty lipids. In: Akoh CC, Lai O-M, eds. Healthful Lipids. Champaign: AOCS Press, 2005; 593.
23. National Heart Foundation Australia. 2004. Accessed October 2005. http:// www.heartfoundation.com.au/index.cfm?page=713
24. Mansour MP, Sinclair AJ. The trans fatty acid and positional (sn-2) fatty acid composition of some Australian margarines, dairy blends and animal fats. Asia Pac J Clin Nutr 1993 ; 2: 155 -63.
25. Clifton PM, Keogh JB, Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. [erratum appears in J Nutr 2004 July; 134 (7): 1848]. J Nutr 2004; 134: 874-9.
26. American Society for Clinical Nutrition and American Institute of Nutrition. Position paper on trans fatty acids. ASCN/;AIN task force on trans fatty acids. Am J Clin Nutr 1996 ; 63: 663-70.
27. Slover HT, Thompson JR, Davis CS, Merola GV. Lipids in margarines and margarine-like foods. J Am Oil Chem Soc 1985; 62: 775-86.
28. Beare-Rogers JL, Hollywood R, O'Grady E. Fatty acids in Canadian margarines. Can J Public Health 1985; 76: 276-7.
29. Wills RBH, Myers PR, Greenfield H. Composition of Australian foods 14. Margarines and cooking fats. Food Technol Aust 1982; 34: 240-4.
30. Noakes M, Nestel PJ. Trans fatty acids in the Australian diet. Food Aust 1994; 46: 124-9.
31. Ratnayake WM, Pelletier G, Hollywood R, Bacler S, Leyte D. Trans fatty acids in Canadian margarines: Recent trends. J Am Oil Chem Soc 1998; 75: 1587-94.
32. Innis SM, Green TJ, Halsey TK. Variability in the trans fatty acid content of foods within a food category: Implications for estimation of dietary trans fatty acid intakes. J Am Coll Nutr 1999; 18: 255-60.
33. USDA Nutrient Database for Standard Reference, Release 14. 2001. Nutrient Data Laboratory Home Page. http://www.nal.usda.gov/fnic/ foodcomp U.S. Department of Agriculture/Agricultural Research Service
34. Stender S, Dyerberg J. The Influence of Trans Fatty Acids on Health. A Report from the Danish Nutrition Council, 4th edn. Publication no. 34. 2003.
35. Regulations Amending the food and drug regulations (Nutritional labelling, Nutrient Content Claims and Health Claims). Department of health, Canada Gazette, Part 11, 2003.
36. Department of Health and Human Services Food and Drug Administration. 21 CFR Part 101 [Docket no. 94P-0036]. Food Labelling: Trans Fatty acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims. Washington, DC: Washington FDA, 2003: 41434-506.
37. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer MJ, Willett WC. Dietary fat and risk of coronary heart disease in men: Cohort follow-up study in the United States. Brit Med J 1996; 313: 84-90.
38. Hu FB, Stampfer MJ, Manson JE et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-9.
39. Howell VH, McNamara DJ, Tosca MA, Smith BT, Gaines JA. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: A meta-analysis. Am J Clin Nutr 1997; 65: 1747-64.
40. Gebauer S, Harris WS, Kris-Etherton PM, Etherton TD. Dietary N-6:N-3 fatty acid ratio and health. In: Akoh CC, Lai O-M, eds. Healthful Lipids. Champaign: AOCS Press, 2005 ; 221 -48.
41. Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1991; 30: 39-103.
42. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 2004; 79: 935-45.
43. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002; 277: 8755-8.
44. Dubnov G, Berry EM. Omega-6/omega-3 fatty acid ratio: The israeli paradox. World Rev Nutr Diet 2003; 92: 81-91.
45. Din NJ, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. Brit Med J 2004; 328: 30-5.
46. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS. Cardiac benefits of fish consumption may depend on type of fish meal consumed: The cardiovascular health study. Circulation 2003; 107: 1372-7.
47. He K, Song Y, Daviglus ML et al. Accumulated evidence on fish consumption and coronary heart disease mortality: A meta-analysis of cohort studies. Circulation 2004; 109: 2705-11.
48. He K, Song Y, Daviglus ML et al. Fish consumption and the incidence of stroke: A meta-analysis of cohort studies. Stroke 2004; 35: 1538-42.
49. Neuringer M, Anderson GJ, Connor WE. The essentiality of n-3 fatty acids for brain development and function of the retina and brain. Annu Rev Nutr 1988; 8: 517-41.
50. Department of Health and Ageing, Australia. Ministry of Health, New Zealand. National Health and Medical Research Council. Nutrient Reference Values for Australia and New Zealand, including recommended dietary intakes. 2004; 285: 265.
51. Sinclair AJ, O'Dea K, Johnson L. Estimation of the n-3 PUFA status of Australians by the analysis of plasma phospholipid fatty acids. Aust J Nutr Diet 1994; 29: 337-43.
52. Sinclair AJ, Oon KS, Lim L, Li D, Mann NJ. The omega-3 fatty acid content of canned, smoked and fresh fish in Australia. Aust J Nutr Diet 1998; 55: 116-20.
53. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: A critical review. J Am Coll Nutr 2001; 20: 5-19.
54. Nicklas TA, Hampl JS, Taylor CA, Thompson VJ, Heird WC. Monounsaturated fatty acid intake by children and adults: Temporal trends and demographic differences. Nutr Rev 2004; 62: 132-41.
55. Kris-Etherton PM, Hecker KD, Bonanome A et al. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med 2002; 113 (9B): 71S-88S.
56. Beauchamp GK, Keast RS, Morel D et al. Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil. Nature 2005; 437: 45-6.
57. Feldman EB. The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 2002; 132: 1062S-1101S.
58. Dreher ML, Maher CV, Kearney P. The traditional and emerging role of nuts in healthful diets. Nutr Rev 1996; 54: 241-5.
59. Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: Effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr 1999; 70: 504S-11S.
60. Hildebrand D, Mamadou L. Genetically engineered oils. In: Akoh CC, Lai O-M, eds. Healthful Lipids. Champaign: AOCS Press, 2005; 526.